Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
5.04
-0.05 (-0.98%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Strata Critical Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 254.27 | 197.14 | 146.82 | 225.18 | 146.12 | 67.16 | |
Revenue Growth (YoY) | -8.61% | 34.28% | -34.80% | 54.11% | 117.58% | 32.92% |
Cost of Revenue | 90.75 | 156.02 | 117.23 | 183.06 | 123.85 | 54.31 |
Gross Profit | 163.52 | 41.13 | 29.59 | 42.12 | 22.28 | 12.85 |
Selling, General & Admin | 38.56 | 60.88 | 50.86 | 105.61 | 70.26 | 42.96 |
Depreciation & Amortization Expenses | - | 2.6 | 1.26 | - | - | - |
Research & Development | 1.37 | - | - | 4.63 | 5.55 | 2.16 |
Total Operating Expenses | 39.93 | 63.48 | 52.11 | 110.24 | 75.8 | 45.11 |
Operating Income | -4.95 | -22.35 | -22.53 | -68.12 | -53.53 | -32.26 |
Interest Income | 3.39 | 4.24 | 7.21 | 8.44 | 3.43 | 0.74 |
Other Non-Operating Income (Expense) | 2.99 | -1.95 | -0.85 | 2.13 | 22.06 | -9.15 |
Total Non-Operating Income (Expense) | 3.59 | 2.29 | 6.36 | 10.58 | 25.5 | -8.41 |
Pretax Income | -16.37 | -20.07 | -16.16 | -57.54 | -28.03 | -40.67 |
Provision for Income Taxes | 0.02 | - | - | -1.47 | -0.77 | -3.75 |
Net Income | -16.39 | -20.07 | -16.16 | -56.08 | -27.26 | -36.92 |
Earnings From Discontinued Operations | - | 61.41 | -11.15 | - | - | - |
Net Income to Common | -16.39 | 41.35 | -27.31 | -56.08 | -27.26 | -36.92 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 83 | 82 | 77 | 74 | 71 | 70 |
Shares Outstanding (Diluted) | 85 | 82 | 77 | 74 | 71 | 78 |
Shares Change (YoY) | 7.82% | 5.93% | 5.41% | 3.21% | -8.30% | 81.15% |
EPS (Basic) | 0.57 | 0.50 | -0.35 | 0.55 | -0.38 | 0.01 |
EPS (Diluted) | 0.57 | 0.50 | -0.35 | 0.55 | -0.38 | 0.01 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -44.78 | -58.51 | -33.38 | -32.35 | -37.86 | -22.12 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.53 | -0.71 | -0.43 | -0.44 | -0.53 | -0.28 |
Gross Margin | 64.31% | 20.86% | 20.15% | 18.71% | 15.24% | 19.14% |
Operating Margin | -1.95% | -11.34% | -15.34% | -30.25% | -36.63% | -48.04% |
Profit Margin | -6.44% | -10.18% | -11.01% | -24.90% | -18.66% | -54.97% |
FCF Margin | -17.61% | -29.68% | -22.74% | -14.37% | -25.91% | -32.93% |
EBITDA | 4.59 | -14.17 | -16.56 | -61.01 | -47.8 | -31.09 |
EBITDA Margin | 1.81% | -7.19% | -11.28% | -27.09% | -32.72% | -46.29% |
EBIT | -4.95 | -22.35 | -22.53 | -68.12 | -53.53 | -32.26 |
EBIT Margin | -1.95% | -11.34% | -15.34% | -30.25% | -36.63% | -48.04% |
Effective Tax Rate | -0.13% | 0.00% | 0.00% | 2.55% | 2.75% | 9.23% |